4Bratovic I, Lacevic N. Management of esophageal varices. Med Arh 2002;56(Suppl 1):11-12.
5Bhasin DK, Malhi NJ. Variceal bleeding and portal hypertension:much to learn, much to explore. Endoscopy 2002;34:119-128.
6Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY,Chang FY, Lee SD. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis. Scand J Gastroenterol 2002;37:482-487.
7Ramirez MC, Martinez-Cuesta MA, D'Ocon P, Noguera MA,Garcia-Zaragoza E, Bosch J, Melin P, Esplugues JV. Comparative effects of the novel vasotocin analogue F-180 vsvasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 2001;364:199-204.
8Ramirez MC, Martinez-Cuesta MA, D'Ocon P, Noguera MA,Garcia-Zaragoza E, Bosch J, Melin P, Esplugues JV. New method of cardiac output measurement using ultrasound velocity dilution in rats. J Appl Physiol 2001;91:1274-1282.
9Garcia N Jr, Sanyal AJ. Portal hypertension. Clin Liver Dis 2001;5:509-540.
10Vlavianos P, Westaby D. Management of acute variceal haemorrhage. Eur J Gastroenterol Hepatol 2001;13:335-342.
